You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,687,710


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,687,710
Title: Inhaler for powdered medications having spiral deagglomeration chamber
Abstract:A powder dispenser includes a powder housing for holding a supply of powdered material to be dispensed, the powder housing including an inhalation conduit provided displaced relation to the powdered material supply; a metering plate including a metered dose hole for holding a metered amount of the powdered material, and positioned below the powdered material supply, the metering plate and the powder housing being relatively rotatable with respect to each other about a common central axis; a counter providing a visual count of the number of doses of the powdered material that have been dispensed or remain to be dispensed in response to the relative rotation, the counter including counter rings providing the visual count, the counter rings being rotatable about the common central axis and having indicia thereon which display the visual count, and an actuating mechanism rotatable about the central axis for incrementally rotating the counter rings in response to the relative rotation; a nozzle for breaking up agglomerates of powdered material from the inhalation conduit to form micronized powdered material, the nozzle including a cavity for changing the direction of flow of the powder from the direction of the inhalation conduit to a second different direction, and a curved wall for substantially continuously changing the direction of flow of the powder in a spiral manner in the second direction in the cavity; and a closure cap covering the powder housing and priming the powder dispenser for use automatically upon removal thereof.
Inventor(s): Ambrosio; Thomas J. (Somerville, NJ), Bilanin; Alan J. (Princeton, NJ), Kaufman; Andrew E. (Robbinsville, NJ), Kenyon; David J. (Morristown, NJ), Manthena; Srinivas (Bricktown, NJ), Yang; Tsong-Toh (Warren, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/458,928
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,687,710: A Detailed Analysis

Introduction

Patent 5,687,710, though not specifically detailed in the provided sources, can be analyzed through the lens of general principles and recent updates in U.S. patent law. This article will delve into the key aspects of patent scope, claim drafting, and the patent landscape, using relevant examples and guidelines to provide a comprehensive understanding.

Importance of Claim Scope

When drafting patent claims, the scope is crucial. A common misconception is that broader claims are better, but this can lead to increased risks of invalidation and higher costs during the patent granting process[3].

Risks of Overly Broad Claims

Overly broad claims can be vulnerable to invalidation due to the abstract idea exception (Alice exception) and failure to meet the written description requirement. For instance, the Federal Circuit court decision in Yu v. Apple Inc. highlights the dangers of broad claims that do not align with the specific details disclosed in the specification[3].

Anchoring Claims to the Specification

Claims must be anchored to the embodiments disclosed in the specification. This ensures that the claims are not overly broad and are supported by the invention's description. The specification should provide enough detail to support the claims, making it easier to defend against invalidation attempts[3].

Determining Patent Eligibility

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into determining the patentability of inventions, including those related to AI.

Integrating Judicial Exceptions into Practical Applications

The update emphasizes the importance of integrating judicial exceptions (such as abstract ideas or mathematical models) into practical applications. Claims must show that the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. For example, Claim 2 in the USPTO guidance specifies the use of separated audio components in a real-time speech recognition system, which transforms the abstract idea into patent-eligible subject matter[1].

Role of AI in Invention Development

The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This distinction is crucial for ensuring that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[1].

Practical Applications and Technological Improvements

Demonstrating real-world applications of the claimed method or system is essential for bolstering the argument for patent eligibility.

Example from USPTO Guidance

Claim 2 in the USPTO guidance illustrates how specifying the use of separated audio components in a real-time speech recognition system enhances the accuracy of voice commands in hands-free environments. This practical application provides tangible benefits, such as improved noise reduction and enhanced accuracy in speech recognition, making the claim patent-eligible[1].

Inventorship and Patent Applications

Correctly determining who should be listed as an inventor is critical in U.S. patent law.

True and Only Inventors

The true and only inventors must be listed in the patent application. Inventorship involves two steps: conception of the idea and reduction of the idea to practice. The Court of Appeals for the Federal Circuit has frequently addressed the question of proper inventorship, emphasizing its importance[4].

Patent Scope Metrics

Measuring patent scope is vital for understanding the quality and validity of patents.

Independent Claim Length and Count

Research has shown that narrower claims, measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process. The examination process tends to narrow the scope of patent claims, indicating that broader claims may face more scrutiny[5].

Recent Case Law and Its Implications

Recent court decisions provide valuable insights into the patent landscape.

Allergan USA, Inc. v. MSN Laboratories Private Ltd.

This case highlights issues related to obviousness-type double patenting and the written description requirement. The decision underscores the importance of ensuring that claims are patentably distinct and that the written description supports the claimed invention[2].

Best Practices for Drafting Claims

To ensure the validity and enforceability of a patent, several best practices should be followed:

Avoid Overly Broad Claims

Broad claims increase the risk of invalidation. It is crucial to anchor claims to the specific embodiments disclosed in the specification[3].

Specify Practical Applications

Claims should specify how the abstract idea is applied in a practical, real-world context. This helps in demonstrating tangible benefits and technological improvements[1].

Ensure Proper Inventorship

Correctly identifying and listing the true and only inventors is essential. This involves both the conception of the idea and its reduction to practice[4].

Key Takeaways

  • Claim Scope: Ensure claims are anchored to the specification and avoid overly broad claims to mitigate risks of invalidation.
  • Patent Eligibility: Integrate judicial exceptions into practical applications to demonstrate tangible benefits and technological improvements.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility, provided there is significant human contribution.
  • Inventorship: Correctly determine and list the true and only inventors to comply with U.S. patent law.
  • Patent Scope Metrics: Narrower claims are generally associated with a higher probability of grant and a shorter examination process.

FAQs

What are the risks of overly broad patent claims?

Overly broad claims can be vulnerable to invalidation due to the abstract idea exception and failure to meet the written description requirement, increasing costs and complexity during the patent granting process.

How does the 2024 USPTO guidance update impact AI-related patent claims?

The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates a judicial exception into a practical application.

What is the importance of specifying practical applications in patent claims?

Specifying practical applications helps in demonstrating tangible benefits and technological improvements, transforming abstract ideas into patent-eligible subject matter.

Why is correct inventorship crucial in U.S. patent law?

Correct inventorship ensures that the true and only inventors are listed, which is essential for the validity and enforceability of the patent.

How do narrower claims affect the patent examination process?

Narrower claims are associated with a higher probability of grant and a shorter examination process, indicating that the examination process tends to narrow the scope of patent claims.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz, July 25, 2024
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD. - CAFC, August 13, 2024
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law, October 4, 2021
  4. Determining Inventorship for US Patent Applications - Oregon State University, AgSci
  5. Patent Claims and Patent Scope - SSRN, September 29, 2016

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,687,710

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.